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Contemporary systems for oocyte retrieval and culture of both cattle and human embryos are suboptimal
with respect to pregnancy outcomes following transfer. In humans, chromosome abnormalities are the
leading cause of early pregnancy loss in assisted reproduction. Consequently, pre-implantation genetic
testing for aneuploidy (PGT-A) is widespread and there is considerable interest in its application to
identify suitable cattle IVP embryos for transfer. Here we report on the nature and extent of chromo-
somal abnormalities following transvaginal follicular aspiration (OPU) and IVP in cattle. Nine sexually
mature Holstein heifers underwent nine sequential cycles of OPU-IVP (six non-stimulated and three
stimulated cycles), generating 459 blastocysts from 783 oocytes. We adopted a SNP-array approach
normally employed in genomic evaluations but reanalysed (Turner et al., 2019; Theriogenology 125: 249)
to detect levels of meiotic aneuploidy. Specifically, we asked whether ovarian stimulation increased the
level of aneuploidy in either trophectoderm (TE) or inner-cell mass (ICM) lineages of blastocysts
generated from OPU-IVP cycles. The proportion of Day 8 blastocysts of inseminated was greater
(P < 0.001) for stimulated than non-stimulated cycles (0.712 ± 0.0288 vs. 0.466 ± 0.0360), but the overall
proportion aneuploidy was similar for both groups (0.241 ± 0.0231). Most abnormalities consisted of
meiotic trisomies. Twenty in vivo derived blastocysts recovered from the same donors were all euploid,
thus indicating that 24 h of maturation is primarily responsible for aneuploidy induction. Chromosomal
errors in OPU-IVP blastocysts decreased (P < 0.001) proportionately as stage/grade improved (from 0.373
for expanded Grade 2 to 0.128 for hatching Grade 1 blastocysts). Importantly, there was a high degree of
concordance in the incidence of aneuploidy between TE and ICM lineages. Proportionately, 0.94 were
“perfectly concordant” (i.e. identical result in both); 0.01 were imperfectly concordant (differing ab-
normalities detected); 0.05 were discordant; of which 0.03 detected a potentially lethal TE abnormality
(false positives), leaving only 0.02 false negatives. These data support the use of TE biopsies for PGT-A in
embryos undergoing genomic evaluation in cattle breeding. Finally, we report chromosome-specific
errors and a high degree of variability in the incidence of aneuploidy between donors, suggesting a
genetic contribution that merits further investigation.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).iversity of Nottingham, LE12
iversity of Kent, Canterbury,
. Griffin), kevin.sinclair@
r Inc. This is an open access articl1. Introduction
The development of optimal systems for oocyte retrieval and
maturation is a priority for cattle IVP and human assisted repro-
duction in order to maximise pregnancy outcomes following em-
bryo transfer (ET). Maturational processes in growing oocytes aree under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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some segregation errors may originate at this stage. Optimising
these processes to ensure faithful chromosome segregation is,
therefore, the primary rate-limiting step in the successful imple-
mentation of systems for in vitro culture (IVC) of mammalian em-
bryos [1e3]. Considerable progress has been made in developing
systems for in vitromaturation (IVM) of germinal-vesicle (GV) stage
oocytes from non-stimulated ovarian cycles [4,5]. Deficiencies
remain, however, that limit the widespread uptake (although not
interest) of oocyte retrieval from such cycles in commercial bovine
(Bos taurus) in vitro embryo production (IVP). As an alternative,
approaches that entail controlled ovarian stimulation and retrieval,
followed by a period of maturation in vitro [6,7] are favored.
Protocols have been developed [8] and refined [9] in cattle based
on the concept that, within stimulated cycles, a short period of
gonadotrophin withdrawal (‘coasting’) prior to follicular aspiration
can enhance the acquisition of developmental competency by oo-
cytes [10]. These protocols can lead to high yields of transferrable-
quality blastocysts per donor cycle. However, molecular mecha-
nisms operating within the follicular compartment that may be
predictive of subsequent oocyte development from such cycles are
only just being elucidated [11]. Moreover, there is limited published
data on pregnancy outcomes following embryo transfer (ET) [12].
Microarray-based transcript analyses of oocytes from ‘coasting
protocols’ of differing duration reveal that genes involved in DNA
recombination, replication and repair, together with those involved
in spindle integrity and chromosome stability, are highly labile [13].
In humans, the extent to which ovarian stimulation can induce
chromosome abnormalities (most of which are lethal) is contro-
versial [14], and it also remains to be determined if ovarian stim-
ulation induces chromosomal abnormalities in cattle.
The trend in human ART over the past decade has been to move
towards extended culture to the blastocyst stage, with emphasis
placed on generating at least one karyotypically normal blastocyst,
determined by preimplantation genetic testing for aneuploidy
(PGT-A) following sampling by trophectoderm (TE) biopsy [15].
This shift in emphasis has been facilitated to a large extent by rapid
improvements in diagnostic approaches such as array comparative
genomic hybridization (aCGH) and next-generation sequencing
(NGS) that allow comprehensive chromosome screening [15]. Ap-
proaches involving single-nucleotide polymorphism (SNP) arrays
to detect monogenic and chromosomal disorders simultaneously in
human pre-implantation embryos are also gaining in popularity
[16,17]. We have recently applied this technology to cattle IVP and
reported the first live births [18]. Detection by this approach reveals
that around 34% of human and 31% of cattle blastocysts are aneu-
ploid [19].
Whilst the study of chromosome abnormalities in cattle em-
bryos and ongoing pregnancies is still in its infancy, they are
established as the leading cause of pregnancy loss, IVF failure,
placental insufficiency and outlier birth weights in humans
[20e22]. In cattle, some breeding (AI) bulls are screened for
balanced chromosome translocations because of deleterious effects
that chromosome abnormalities can have on future pregnancies
[23]. In humans, there is convincing evidence that PGT-A can
reduce miscarriage rates and improve time to first pregnancy [15].
However, PGT-A has not been established in commercial bovine
IVP-ET despite the fact reduction in pregnancy loss following ET is a
key consideration. This is the subject of ongoing studies at our
collaborative laboratories.
With the foregoing discussion in mind, the current study sought
to establish the nature and incidence of chromosomal abnormal-
ities in both stimulated (coasting) and non-stimulated cycles of
transvaginal follicular aspiration (Ovum Pick-Up; OPU) and IVP in
cattle. Specifically, we tested the hypothesis that ovarian109stimulation significantly increases the yield of oocytes for insemi-
nation but not at the expense of an increase in chromosome ab-
normalities. In order to achieve this, we employed a SNP-array
platform that was recently adapted for PGT-A in cattle [18]. This
makes use of data generated from the GGP 50K SNP array (Neogen
Europe Ltd, UK) used routinely to establish cattle genomic esti-
mated breeding values (gEBVs). The attractiveness of this approach
is that, from TE biopsies, it could present breeders with the op-
portunity to make selection decisions based both on the genetic
merit (gEBV) of the embryo [24] and, following PGT-A, its ploidy
status. Theoretically, therefore, its potential to give rise to a viable
pregnancy following ET should be improved. A further objective of
the current study was to test the hypothesis that there is complete
(or near complete) concordance in terms of chromosomal abnor-
malities between the TE (fromwhere the cells are sampled) and the
inner-cell mass (ICM). Whilst high concordance has been observed
for human blastocysts [25,26], this is yet to be established for cattle.
Such information will be essential when considering imple-
mentation of a cattle PGT-A programme, as selection decisions
about the genome of the ICM derived fetus are based solely on
information gleaned from TE biopsies.
2. Materials and methods
2.1. Generic considerations
All procedures adhered to the Animals (Scientific Procedures)
Act, 1986. Associated protocols complied with the ARRIVE guide-
lines and were approved by the University of Nottingham Animal
Welfare and Ethical Review Body (AWERB). All chemicals and re-
agents were sourced through Sigma-Aldrich Company Ltd (Dorset,
UK) unless otherwise specified.
2.2. Animals and transvaginal follicular aspiration
Nine sexually mature 16-20 month-old virgin Holstein-Friesian
heifers underwent initial estrous synchronization. Briefly, an
intravaginal progesterone (P4)-releasing device (CIDR Vaginal De-
livery System, 1.38g, Zoetis UK Ltd, Leatherhead, UK) was inserted
and a GnRH analogue (Acegon, Zoetis UK Ltd, Leatherhead, UK)
administered (2 mL i. m.). The prostaglandin (PGF2a) analogue
Cloprostenol (Estrumate, MSD Animal Health, UK) was adminis-
tered (2 mL i. m.) six and seven days later, at which time the CIDR
was removed. GnRH (2 mL i. m.) was administered again 48 h later
in order to assist ovulation.
Transvaginal ovarian follicular aspiration (ovum pick-up; OPU)
commenced 4 d after estrus onset and was repeated twice weekly
(every 3e4 days) for 3 weeks, leading to a total of 6 cycles of ‘Non-
stimulated’ OPU. All OPU procedures were undertaken in a dedi-
cated theatre where the ambient temperature was maintained
between 28 and 33 C. Cumulus-oocytes complexes (COCs) were
aspirated as described previously [18]. Briefly, OPU used a Cook
Medical vacuum pumpwith a 7.5 MHz ultrasound scanner (Exapad,
IMV Imaging, Glasgow, UK) with aspiration pressure set at
70mmHg. COCs were aspirated through an 18G needle and 1.4 m of
1.4 mm (I.D.) silicone tubing into 5 mL of Tyrodes lactate (TL) based
aspiration media, as described previously [9].
Stimulated cycles of OPU using the same donors followed
immediately and were undertaken once every 14 days over a five-
week period, leading to a total of 3 cycles. The protocol commenced
with ablation (aspiration) of all follicles  5 mm in diameter
(dominant follicle removal; DFR) five days after the final non-
stimulated session of OPU. A CIDR was inserted following DFR
and ovarian stimulation commenced 48 h later. This involved six
injections (i.m.) of follicle stimulating hormone (FSH; Folltropin,
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12 h intervals. The first stimulated session of OPU was undertaken
approximately 38e42 h following final FSH injection. The proced-
ure for OPU and oocyte collection was as described for non-
stimulated cycles. Following OPU, a replacement CIDR was inser-
ted and the subsequent cycle of DFR commenced 8 days later.
2.3. In vitro embryo production (IVP)
OPU aspirants were passed through a heated (~37 C) filter, and
filtrates transferred to 100 mm petri dishes on a heated stage
(~38 C) for COC retrieval. COCs were graded 1e4 according to
Ref. [27,28]. All COCs with sparse, expanded or absent cumulus or
with fragmented, pale or irregular cytoplasm were classed Grade 4
and rejected. Grade 1e3 COCs were matured as previously
described [18] in HEPES buffered TCM199 media supplemented
with 10% (v/v) FBS, 4 mg/mL fatty acid free BSA, 0.2 mM pyruvate,
50 mg/mL gentamicin, 5 mg/mL FSH, 0.5 mg/mL LH, 1 mg/mL E2, in a
screw top cryovial (Thermo Fisher Scientific Inc. Loughborough,
UK) at atmospheric CO2 and 38.5 C, for 23e24 h.
Fertilization occurred in 50 mL drops (5 oocytes/drop) under oil.
Media consisted of modified TL media as previously described [9]
supplemented with 0.6% (w/v) fatty acid free BSA, 1.5 mg/mL hep-
arin, 0.2 mM sodium pyruvate, 0.08 mM penicillamine, 0.04 mM
hypotaurine, 10 mM epinephrine, 50 mg/mL gentamicin. Frozen/
thawed semen from a single sire was used throughout. Sperm
preparation was by centrifugation through a 45%/90% BoviPure
(Nidacon, M€olndal, Sweden) gradient. 2 mL of sperm preparation
was added to each drop to give a final concentration of 70,000
sperm per drop. Oocytes and spermwere co-incubated for 18e21 h
in a humidified environment of 5% CO2 in air at 38.5 C.
Embryoswere cultured (up to 11 per 10 mL drop) inmodified SOF
based sequential culturemedia (mSOF), as previously described [9],
in a humidified environment under oil at 5% CO2, 5% O2 and 38.5 C.
Cleavage was assessed on Day 2 (30 h following transfer) and
embryos classified according to cell number (i.e. 1, 2e3, and
>4 cells). Embryos were transferred approximately 42 h later (Day
4) to 10 mL drops of the second culture media. Progression to
morula was assessed 48 h later (Day 6), and embryos transferred to
20 mL drops of the third culture media. Embryos were assessed
again 48 h later (Day 8) for stage and quality in accordance to the
International Embryo Transfer Society (IETS) guidelines for bovine
embryo assessment [29].
2.4. In vivo embryo collection
One month following the final session of Stimulated OPU, 8 of
the original 9 heifers (one had become lame andwas removed from
the study) underwent estrous synchronization using the drugs and
doses described in Section 2.2, and according to the following
schedule: CIDR insertion on Day 10, PGF2a on Day 4, CIDR
withdrawal on Day 2, with estrus detected between Day 1 and
Day 2. A second CIDR was inserted on Day 7 of the cycle, followed
by GnRH (i.m.) on Day 9, and initiation of ovarian stimulation
commenced on Day 11. This involved eight injections of FSH (Foll-
tropin; i. m. every 12 h, reducing by 0.5 mL each day from 2.5 mL to
1 mL). PGF2a (i.m.) was administered on the morning of Day 13, and
artificial insemination (AI) commenced 48 h later, on Day 15, and
was repeated three times at 12 h intervals.
Day 7 embryos were subsequently flushed transcervically
following initial AI. Briefly, following light sedation (0.25mL/100 kg
i. m. xylazine hydrochloride; Rompun 2% w/v, Bayer Animal Health,
Reading, UK) and epidural (adrenaline, lignocaine hydrochloride;
3e5 mL 2% w/v, Lignol, Dechra Veterinary Products, Shrewsbury,
UK) anaesthesia, a Foley catheter was passed through the cervix110and placed in each uterine horn. Three x 50 mL syringes containing
Vigro™ Flush Media (Vetoquinol UK Ltd, Towcester, UK) was used
to flush each horn. Flushes were passed over a 70 mM filter to
recover embryos. Embryos were held in 2 mL of SOFaai [30] sup-
plemented with 25 mM HEPEs media at 38 C in transportable
incubator until transported to the lab. A total of 21 embryos were
retrieved from 5 donors. Recovered Day 7 in vivo derived blasto-
cysts and morula were cultured for 24 h in SOFaai culture media
[30] in 20 mL drops (up to 11 per drop, within donor) under oil at 5%
CO2, 5% O2 and 38.5 C, and subsequently graded as described for
in vitro produced embryos.
2.5. Immunodissection, RNA and DNA extraction, and DNA
amplification
A total of 336 (117 non stimulated, 219 stimulated) OPU-IVP
derived and 20 (from same OPU donors) in vivo derived Day 8
blastocysts (IETS stages 6e9) underwent immunodissection to
isolate the trophectoderm (TE) and inner-cell mass (ICM). Immu-
nodissection was performed as described previously [31]. Briefly,
the zona pellucida (ZP) was removed by 30e60 s exposure to 10 mg/
mL pronase in TCM199. ZP free embryos were incubated for 60 min
in 50% anti bovine sera in mSOF, washed, then incubated for 2 min
50% Guinea pig complement sera in mSOF. Each embryo was
washed individually through PBS/PVP (Ca/Mg free PBS þ 0.1% PVP),
placed in a 5 mL drop of PBS/PVP under oil, and held on a warm
stage for 40 min. Disaggregation was induced by pipetting using a
fine-bore glass pipette. TE cells were transferred to a PCR tube
containing 4 mL PBS and held on ice. The ICM was pipetted
repeatedly to remove any adherent TE cells and the remaining ICM
was then also transferred to a PCR tube. A sub-sample of immu-
nodissected blastocysts (n ¼ 75) were assessed for the expression
of the TE specific marker GATA3 [32] by qPCR (Supplemental
Information Table S1). This confirmed good (P ¼ 0.003) separa-
tion of the two blastocyst lineages (Supplemental Information
Fig. S1). Remaining samples of TE and ICM were frozen at 80 C
until further analyses.
2.5.1. Retrospective sample allocation
Nine ICM and nine TE of IETS Stage 7 (Grade 1 and 2), 8 and 9 (all
Grade 1) blastocysts per donor, per treatment were selected for
chromosomal analysis. Where 9 or less embryos were available, all
Stages 7 (Grade 1 and 2), 8 and 9 were taken; if more than 9 em-
bryos were available, blastocysts were randomly selected by stage
in proportions that represented the stages exhibited by that donor
for Stimulated and Non-stimulated cycles. A total of 82 blastocysts
from Stimulated OPU cycles and 70 blastocysts from Non-
stimulated were selected. All Stage 7 (Grade 1 and 2), 8 and 9
immunodissected in vivo derived (n ¼ 20) blastocysts were
selected.
2.6. DNA extraction
White blood cells (WBC) fromwhole blood of OPU donors were
pelleted by centrifugation (2500 rpm for 3 min, followed by
14,000 rpm for 2 min). Semen samples (from the single sire used in
these studies) werewashed in PBS and pelleted by centrifugation at
14,000 rpm for 2 min. DNA was extracted from WBC and sperm
using a salting-out method [33]. Briefly, cells were lysed by over-
night incubation at 55 C in 800 mL of 8 mM Tris/0.1 mM EDTA
buffer with 0.01% (w/v) proteinase K and 0.5% (w/v) SDS; and for
sperm cells only with 10 mM DTT. To reduce clumping 1.5 mL of
20 mg/mL proteinase K was added and lysed blood cells further
incubated for 3 h at 55 C. Following lysis, 360 mL of 5 M NaCl was
added and solution centrifuged at 14,000 rpm for 5 min to remove
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ethanol precipitation.
2.6.1. Whole-genome amplification (WGA)
WGA used a REPLI-g single cell WGA kit (Qiagen, Manchester,
UK) as per manufacturer’s instructions. Briefly, samples were de-
natured in a final volume of 40 mL denaturation buffer (supplied
with kit) containing 75 mM DTT, by incubation at 65 C for 10 min,
which was ceased by the addition of 3 mL stop solution (supplied).
WGA was achieved by the addition of 40 mL of master mix (sup-
plied), containing Phi 29 polymerase, and incubation for 4 h at
30 C, followed by 3 min at 65 C to cease the reaction. Amplified
DNA was stored at 20 C until analyses.
2.6.2. Quality assurance/sexing
All WGA DNA was submitted to PCR to assess amplification, to
identify sex and to confirm concordance between TE and ICM lin-
eages of individual blastocysts. Briefly, a multiplex PCR incorpo-
rated two primer sets: a primer set for SRY (GenBank accession no.
EU58186.1 e designed in house using Primer-Blast (NCBI)) was
used to identify male sex (TGAAACAAGACCAAAACCGGG forward,
TCCATGGACTTGCTCTACTGT reverse; amplicon 339bp), and BSP
[34] was used as an autosomal marker (TTTACCTTAGAA-
CAAACCGAGGCAC forward, TACGGAAAGGAAAGATGACCTGACC
reverse, amplicon 538bp). The PCR was carried out in a 25 mL re-
action mix containing 12.5 mL of Immomix Red mastermix (Bioline
Reagents Ltd, London, UK) and 0.05 mM each of the primer sets for
BSP, 0.5 mM each of the primer set for SRY, and 1 mL of WGA DNA.
The PCR program used an initial denaturation step at 95 C for
10 min, then 30 cycles at 94 C for 30 s, 55 C for 30 s, and 72 C for
60 s; a final cycle of 72 C for 7 min then held at 10 C.
2.7. Single nucleotide polymorphism (SNP) genotyping and
chromosomal analysis
Whole genome amplified embryonic DNA (from both TE and
ICM) and parental DNAwere submitted to Neogen Europe Ltd (Ayr,
Scotland, UK) for genotyping using a GGP 50K SNP array (Neogen
Europe Ltd, UK). For this database, the average “Call Rate” (fraction
of SNPs successfully genotyped) obtained was 95.8% ± 0.18%, and
the average “Gene Call” (GC) scores (an estimate of the reliability of
each genotype call) were GC50 ¼ 0.747 ± 0.001, and
GC10 ¼ 0.424 ± 0.005. Raw data from the SNP output files for GC
scores and signal strength measurements (X and Y) were employed
to compile a full chromosomal analysis and to characterise the
quality and origin (maternal/paternal and mitotic/meiotic) of
aneuploidy. The tests employed included Karyomapping, B-allele
frequency (BAF) and log R ratio (LRR) graphs, Gabriel-Griffin plots
(GG-plots), and a mosaicism estimation model, all of which are
further described below. During chromosomal analysis, operators
were blinded with respect to the IVP protocol followed to produce
the embryos.
2.7.1. Karyomapping
Karyomapping was initially employed to detect many forms of
aneuploidy (supplemental information, Table S2) and to identify
the parental origin of these chromosome errors. Computations on
the raw SNP database were performed onMobaXterm (version 11.1,
build 3860, Mobatek). Information on individual embryo cell line-
ages plus their parents were extracted from the database. Individ-
ual samples were clustered by parental origin, and sibling embryos
were analysed together in groups of three, resulting in six cell
lineages (three TE and three ICM lineages) analysed together in the
same output file. In each set, a cell lineagewas selected to serve as a
reference individual to permit Karyomapping haploblock tracing,111as previously described [18]. The reference was later swapped to a
different sample, to permit the analysis of all six cell lineages in
each set. The analysis of the individual files was completed via the
Microsoft Excel macro BoVision (version 3.1, University of Kent), as
previously described [18]; however, the macro was upgraded to
process multiple files at the same time. Whole chromosome errors
were determined for all the samples in study. Chromosome Y and
paternal chromosome X errors were excluded as these cannot be
detected by Karyomapping (these chromosomes are present in
single copy in the sire; haploblock tracing is thus prevented).
2.7.2. Log R ratio (LRR) and B allele frequency (BAF) graphs
LRR and BAF graphs were used to further validate the diagnosis
obtained by Karyomapping but also to provide a method to
discriminate between loss of heterozygosity and monosomy and to
detect certain trisomies of mitotic origin. The analysis pertaining to
LRR and BAF graphs was conducted in R (R Core Team, 2014) and
figures were produced using the package karyoploteR [35]. Samples
identified as euploid by Karyomapping were used to calculate
standard R and Theta values for each SNP combination (RAA, RAB,
RBB, ThetaAA, ThetaAB, ThetaBB) from signal intensity data (X and
Y) available from the SNP database itself. We employed the same R
and Theta definitions recommended in Ref. [36]. These values (R
and Theta) were then used to calculate the relevant data points for
each LRR and BAF graph, as previously described [36]. A threshold
was also employed so that only data points with GC > 0.60 were
plotted.
2.7.3. GG plots
GG plots were employed to clarify the origin (meiosis I, meiosis
II, mitosis) of each trisomy detected by Karyomapping, or LRR/BAF
methods. Computations on the raw SNP database as relevant to the
production of GG-plots were performed in the same way described
in Section 2.7.1Output files containing the appropriate information
for each sample were processed through the VBA macro BoVi-
sionGG (version 1.0, University of Kent). The GG-plots were drawn
using the exact algorithm described in Ref. [37], and BoVisionGG
was employed to automatically handle the drawing of multiple
plots.
2.7.4. Mosaicism
For each aneuploidy, mosaicism diagnoses at whole chromo-
some level were inferred by calculating the ratio between the
average LRR values for the affected chromosome (LRRa) and the
expected LRR value (LRRe) for the same chromosome when in
monosomy or trisomy configuration (using the appropriate LRRe
for either a monosomy or a trisomy). The LRRe values were calcu-
lated from the database in study by averaging all LRR values from
aneuploid cases by chromosome and aneuploidy type (monosomy/
trisomy); a variance threshold of <1 was implemented. A fixed and
identical correction factor was added to both LRRa and LRRe values;
this was equal to the difference between the average LRR of all
euploid samples and 0. This factor was included to correct for the
difference observed between the obtained LRR values and the
theoretical average LRR value for euploid samples (zero). The ratio
LRRa/LRRe was then used as a simple way to provide an indication
for the presence and percentage of mosaicism for each chromo-
some abnormality previously detected (by Karyomapping, LRR and/
or BAF analysis). In accordance with the suggestions made by
Ref. [38], chromosomal errors presenting ratios >0.8 were classified
as being in a non-mosaic configuration (affecting the whole cell
lineage), whilst errors with ratios between 0.2 and 0.8 were
considered mosaic; the ratio itself providing an indication for the
proportion of cells affected by the mosaic phenotype. All calcula-
tions were performed in R.
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Analyses were performed using the GenStat statistical package
(19th Edition, VSN International, 2018; https://www.vsni.co.uk/).
All proportion data were analysed using REML generalized linear
mixed models that assumed binomial errors and used logit-link
functions. In these models ‘Donor’ formed the random model
when testing the effects of ‘Treatment’ (i.e. stimulated vs non-
stimulated) which was added as a fixed effect. Blastocyst ‘Stage/
Grade’ was also added as a fixed effect in some models of chro-
mosomal abnormalities. These anlayses of chromosomal abnor-
malities were initially undertaken for trophectoderm (TE) and
inner-cell mass (ICM) lineages separately (to avoid inflating de-
grees of freedom). ‘Lineage’ (i.e. trophectoderm vs inner-cell mass)
was subsequently added as a fixed effect to these models. Analyses
of the number of follicles aspirated, oocytes retrieved and chro-
mosome error classification assumed Poisson errors and used log-
link functions. Data are presented as means ± SEM. Follicle size
distribution was analysed using chi-square tests.
3. Results
In total, 783 COCs (424 from stimulated and 359 from non-
stimulated cycles) were retrieved by OPU of which proportion-
ately around 0.88 were inseminated following IVM. This generated
459 Day 8 blastocysts of which 152 of the more advanced stages
(IETS 7e9) were chosen for analysis of chromosome copy number.
In addition, we were successful in recovering and analysing 20
in vivo produced embryos from five of the same donors.
3.1. Ovarian stimulation significantly improves all measures of IVP
All measures of oocyte retrieval and IVP were improved through
the use of ovarian stimulation (coasting protocol) (Table 1). Follicle
diameter at the point of aspiration was greater (P < 0.001) for
stimulated than non-stimulated cycles (supplemental information,
Fig. S2). The number of follicles aspirated, oocytes retrieved per
cycle and per follicle were all also greater (P < 0.001) for the
stimulated cycles (Table 1). Similarly, the proportion of high-quality
COCs (Grades 1 and 2) was improved (P < 0.001). By Day 2
following insemination, the proportion cleaved of inseminated was
marginally (i.e. 0.945 vs 0.887) greater (P < 0.001) for stimulated
than non-stimulated cycles; the same marginal improvement was
also evident with regard to the developmental stage of zygotes.
Ultimately, Day 8 blastocyst yields and quality (based on morpho-
logical grade) were enhanced (P < 0.001) for oocytes derived from
stimulated relative to non-stimulated cycles.
3.2. Chromosomal abnormalities are not affected by ovarian
stimulation but decline during embryo development and differ
between donors
The proportion of embryos selected for aneuploidy screening
that were male averaged 0.592 ± 0.0398 and did not differ between
ovarian stimulation treatments. Example plots (based on Turner
et al. [18]) for euploid and aneuploid cases are presented in Fig. 1.
The overall incidence of aneuploidy for these 152 OPU-IVP Day 8
(IETS stage 7e9) blastocysts was 0.241 ± 0.0231 and this value did
not differ significantly between stimulated and non-stimulated
cycles (Fig. 2A). This indicates that ovarian stimulation followed
by coasting does not increase the levels of aneuploidy per se.
Comparison to in vivo derived blastocysts (matched for the five
common donors from which these embryos were collected) did,
however, reveal a significant (P < 0.001) difference. That is, all 20
in vivo derived blastocysts were chromosomally normal (euploid)112(Fig. 2B). Given that these in vivo derived blastocysts also originated
from stimulated cycles, this observation further points to IVM/IVC
as the primary cause of chromosomal abnormalities.
The incidence of chromosomal abnormalities was generally
lower (P < 0.01) in the developmentally more advanced Day 8
blastocysts (IETS Stage 8/9) compared to less advanced Stage 7; and
in better quality embryos (morphological Grade 1 vs Grade 2) as
shown in Fig. 3. However, there was an interaction (P < 0.05) be-
tween ovarian-stimulation treatment and blastocyst stage/grade.
This indicated that, although the incidence of chromosomal ab-
normalities decreased as stage/grade improved for blastocysts from
non-stimulated cycles, curiously it was greatest for expanded
(Stage 7) Grade 1 blastocysts from stimulated cycles.
In contrast to the overall effects of ovarian stimulation, there
was a marked (P ¼ 0.008) difference in the proportion of chro-
mosomally abnormal blastocysts between donors (Fig. 4). That is,
virtually all blastocysts from Donors 805 and 859 were euploid,
whereas a relatively high proportion of blastocysts from Donor 835
were aneuploid.
3.3. Chromosomal abnormalities were predominantly maternal
meiotic aneuploidy or (hypo)triploidy
A total of 40 OPU-IVP blastocysts were found to have an ab-
normality in at least one lineage. Abnormalities largely sub-divided
into aneuploidy (including double aneuploidy) and triploidy
(including hypotriploidy) (Fig. 5). A total of 11 (proportionately
0.28) were single maternally derived trisomies and 7 (~0.18) were
single maternal monosomies. Five (0.125) were double aneu-
ploidies (a double trisomy, a double monosomy and three trisomy/
monosomy). We observed no single or double paternally-derived
aneuploidies. A total of 5 (0.125) were triploid (4 maternal, 1
paternal) and 2 hypotriploid (2 maternal, 0 paternal), with a single
embryo having only a maternal genome indicating parthenogen-
esis. All of the above had the same karyotype in ICM and TE.
Of the remaining 9 (~0.23) non-concordant embryos, four were
triploid in one lineage and euploid in the other, and one was trip-
loid in the TE and parthenogenetic in the ICM. One blastocyst was
euploid in the TE and exhibited UPD in the ICM. The three
remaining blastocysts were paternal hypotriploids, two of which
were euploid in one lineage; the other had predominantly paternal
chromosomes (two of which were lost in the TE) with evidence of
persistent maternal chromosomes in the ICM. However, the overall
incidence of specific categories of chromosomal error did not differ
between blastocysts generated from stimulated and non-
stimulated cycles.
Although it was not possible to analyse formally errors on a
chromosome-by-chromosome basis, due to small numbers, chro-
mosome 15 (5x) plus chromosome 1 (4x), and 4 and 14 (3x each),
were particularly over-represented (Fig. 6A). The incidence of
aneuploidy appeared greater for the larger autosomes (i.e. chro-
mosomes 1e9), although this did not reach statistical significance
(Fig. 6B).
3.4. Broad concordance between ICM and TE lineages
The incidence of aneuploidy was similar for both the ICM and TE
lineages (Fig. 7). Moreover, of the 152 OPU-IVP embryos (82 stim-
ulated, 70 non-stimulated) assessed for chromosome abnormalities
in both cell lineages, 143 (proportionately 0.94) were perfectly
concordant; that is the diagnosis was identical in the TE and ICM
(Fig. 8). Of the remaining 9 (0.06), 2 (0.01) were “imperfectly
concordant”; that is a dissimilar abnormality was observed in the
TE and ICM (so a TE biopsy would detect an error). This left 7 (0.05)
with a discordant result (normal in one lineage but abnormal in the
Table 1
Effect of ovarian stimulation on oocyte recovery and in vitro embryo production over three stimulated cycles preceded by six non-stimulated of transvaginal follicular
aspiration (OPU). All expected measures of improvement favour the stimulated (with coasting) protocol.
Stimulated (coasting) Non-stimulated P
Number of cycles 3 6
Aspiration
Number of follicles aspirated per cycle 27.3 ± 1.31 15.0 ± 0.62 <0.001
Number of oocytes retrieved per cycle 19.5 ± 1.1 7.9 ± 0.44 <0.001
Number of oocytes retrieved per follicle 0.710 ± 0.0182 0.526 ± 0.0174 <0.001
Oocyte Culture
Number of Oocytes matured per cycle 18.6 ± 0.91 6.7 ± 0.35 <0.001
Proportion of Grade 1 COCs 0.391 ± 0.0232 0.118 ± 0.0155 <0.001
Proportion of Grade 2 COCs 0.258 ± 0.0208 0.186 ± 0.0187 0.01
Proportion of Grade 3 COCs 0.310 ± 0.0220 0.499 ± 0.0241 <0.001
Proportion of Grade 4 COCs 0.041 ± 0.0094 0.197 ± 0.0192 <0.001
Day 2 cleavage-stage embryos
Number of oocytes inseminated per cycle 17.9 ± 0.88 6.5 ± 0.36 <0.001
Proportion of inseminated oocytes cleaved 0.945 ± 0.0124 0.887 ± 0.0197 0.017
Proportion at 2 cell stage 0.017 ± 0.0064 0.078 ± 0.0155 0.001
Proportion at 3e4 cell stage 0.110 ± 0.0200 0.140 ± 0.0260 NS
Proportion at >4 cell stage 0.872 ± 0.0223 0.782 ± 0.0332 0.019
Day 8 blastocysts
Proportion of inseminated oocytes 0.712 ± 0.0288 0.466 ± 0.0360 <0.001
Proportion of cleaved zygotes 0.753 ± 0.0272 0.525 ± 0.0369 <0.001
Proportion reaching Stagea 8 or 9 0.561 ± 0.0325 0.370 ± 0.0440 <0.001
Number reaching Stagea 8 þ 9 per cycle 7.2 ± 0.65 1.1 ± 0.17 <0.001
Number reaching Stagea 7(1&2)b to 9 per cycle 11.1 ± 0.92 2.2 ± 0.27 <0.001
a IETS scale [29].
b (morphological grade).
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diagnostic setting (i.e. a TE biopsy would have incorrectly indicated
an abnormal embryo) and 3 (0.02) a “false negative” (i.e. a normal
result returned for an abnormal embryo). Of the 9 “not perfectly
concordant” returns, 5 were from stimulated and 4 from non-
stimulated cycles (not statistically significant).
Signal intensity analysis allowed mosaic embryos with between
20 and 80% mosaicism to be identified. Five of the mosaic embryos
were predominantly aneuploid (4 trisomy,1monosomy) with some
euploid contribution in one or both lineages. Of the trisomies, one
wasmosaic in both the TE and ICM, twomosaic only in the ICM and,
one mosaic only in the TE. The monosomy was mosaic only in the
TE. For all these samples, the aneuploidy was estimated to affect
>50% of the sample (range from 53 to 77%). A single predominantly
euploid embryo was identified as mosaic for UPD restricted to the
ICM, but it was not possible to ascertain the proportion of the
sample affected.
4. Discussion
A number of key findings emerge from the current study. We
accept our first hypothesis that ovarian stimulation leads to a sig-
nificant increase in the yield of high-quality oocytes and potentially
transferrable blastocysts, but not at the expense of an increase in
aneuploidy. Our second hypothesis that there is strong concor-
dance between the aneuploidy diagnosis made from the TE and
that of the ICM lineage is also accepted. Our incidental findings are
that levels of aneuploidy are lower in developmentally more
advanced and morphologically better-quality blastocysts, that
there is a significant degree of variability in the incidence of
aneuploidy between oocyte donors, and that there is evidence that
some chromosomes are more prone to non-disjunction in the
oocyte.
4.1. Stimulated vs non-stimulated cycles
Ovarian stimulation is commonly practiced in Bos taurus cattle
undergoing OPU although there is increasing interest in reducing113the level of hormonal interventions in these genotypes. In the
current study, the ‘coasting’ ovarian stimulation protocol led to a 5-
to 7-fold increase in the yield of developmentally advanced and
morphologically good quality Day 8 blastocysts per donor cycle
over the non-stimulation protocol (Table 1). This improvement in
yield was greater than that which could be achieved with the
increased frequency (4 vs 1) of non-stimulated cycles over a stan-
dard 14-day period. The benefits of ovarian stimulation over non-
stimulation would be enhanced further if these embryos led to
improved pregnancy outcomes following ET. This is the subject of
ongoing investigations at our collaborating laboratories.
With the foregoing discussion in mind, it is important to
emphasize that the observed improvement in blastocyst yield was
not at the expense of an overall increase in aneuploidy. That is, the
incidence of chromosomal abnormalities (at ~0.24 of embryos
tested) was not elevated when ovarian stimulation (with coasting)
was employed. It is notable, however, that there were some dif-
ferences in the nature of chromosomal errors between stimulated
and non-stimulated cycles. The incidence of ‘double errors’, which
consisted combinations of maternal trisomy and/or monosomy on
two separate chromosomes, was numerically greater in blastocysts
from non-stimulated cycles. Conversely, the incidence of maternal
trisomy on single chromosomes was greater in blastocysts from
stimulated cycles (Fig. 5). In contrast to OPU-IVP blastocysts, all our
in vivo derived embryos from the same donors were euploid.
Although caution is advocated when interpreting this observation
(given their relatively low numbers; n ¼ 20 in vivo derived em-
bryos), the highly significant difference, and the predominance of
maternal meiotic errors, implicates the 24-h culture period be-
tween OPU and insemination as the time point at which most ab-
normalities arise.
4.2. Effect of stage and grade
The overall incidence of chromosomal abnormalities was lower
in the developmentally more advanced Day 8 blastocysts (propor-
tionately 0.128 vs 0.373 for hatched/hatching vs expanded) indi-
cating an association between advanced development and
Fig. 1. Chromosome analysis outputs of bovine blastocysts. Each aneuploidy was analysed by multiple algorithms: Karyomapping, Signal strength intensity metrics (BAF and LRR)
and, in the case of trisomies, Gabriel-Griffin plots. With Karyomapping, a diagram for each chromosome illustrates which haploblocks the embryo inherited from its dam (yellow/
green) and sire (blue/red). Euploid chromosomes are identified by few, continuous blocks of yellow/green or blue/red bands, a pattern that becomes altered in aneuploidy resulting
in excessive banding in trisomies and absent haploblock inheritance in monosomies. Signal strength intensity graphs plot the signal strength intensity of SNP alleles A and B relative
to each other (for BAF plots) or combined (in LRR plots). Euploid chromosomes display 3 signal clusters in a BAF plot according to each genotype (BB ¼ 1, AB ¼ 0.5, AA ¼ 0) and a
single consistent cluster of data close to the average expected signal intensity in LRR the plots. Monosomies appear as a loss of the AB cluster in the BAF graph and a decrease in
signal intensity in the LRR graph for a specific chromosome; conversely, trisomies result in the gain of an additional signal cluster in a BAF graph (for the possible allele combi-
nations BBB, ABB, AAB, AAA) and an increased signal intensity on the LRR graph for the specific chromosome. In Gabriel-Griffin Plots, for each trisomy, parental haploblocks are
defined and a diagram is drawn highlighting heterozygous genotype calls in red and homozygous calls in yellow. Trisomies originating in Meiosis I show an uninterrupted het-
erozygous pattern around the centromere, Meiosis II error are identified by yellow blocks around the centromere, and mitotic errors are characterized by a variegated yellow and
red pattern across the chromosome. (A) Top ¼ Euploid Karyomapped chromosome 1; Middle (in red) and Bottom (in blue) ¼ BAF and LRR graphs (respectively) also demonstrating
an euploid karyotype. (B) Top ¼ Monosomy 26 of maternal origin, note the absence of any yellow/green (maternally inherited) haploblocks; Middle (in red) and Bottom (in blue),
BAF and LRR graphs (respectively) demonstrating the same monosomy (arrows). (C) Top ¼ Trisomy 14 of maternal origin, note the excess yellow/green banding; Middle (in red) and
Bottom (in blue) graphs ¼ BAF and LRR graphs (respectively) demonstrating the same trisomy (arrows); Bottom most ¼ Gabriel-Griffin plot suggesting this trisomy originated in the
maternal germline during Meiosis I (due to the prominent red pattern encompassing the top two thirds of chromosome 14 and, therefore, its centromere). (For interpretation of the
references to colour in this figure legend, the reader is referred to the Web version of this article.)
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ally considered poor indicators of euploidy in human embryos
[39,40], several studies have reported associations between
morphological grade and the incidence of chromosomal abnor-
malities in both cleavage- [41e45] and blastocyst-stage [39,46e50]
embryos. In contrast, the very few reports describing such associ-
ations in bovine embryos are conflicting and reliant on superseded
technologies [51,52]. In the current study, the declining incidence of
chromosomal errors with morphological stage is in line with
studies reporting arrest [53] or reduced rates of progression [54]
linked to chromosomal errors in human embryos. For morpho-
logical grade, we observed some qualitative differences in that
monosomies occurred more often (~70%) in lower grade expanded
blastocysts, whereas trisomies were the predominant error
observed in higher grade expanding, hatching and hatched blas-
tocysts; a pattern also observed in human embryos [47].
The increase in aneuploidy in Grade 1 expanded (Stage 7)
blastocysts derived from stimulated cycles (Fig. 3) is of interest.114These errors consisted mostly of maternal trisomies on single
chromosomes which, in human embryos, don’t associate with
adverse morphology [50] and are generally considered to be more
compatible with development [55]. In contrast, chromosomally
abnormal Stage 7, Grade 2 blastocysts were mostly monosomic or
were triploid/hypotriploid; and these errors are more likely to
associate with adverse morphologies [47,48] and to be embryonic
lethal [56]. Reasons for this association are unclear, but if it could be
corroborated, then it would have important implications for blas-
tocyst selection from stimulated cycles based solely on morpho-
logical criteria. We have yet to establish, however, if any of these
differences might affect pregnancy outcomes following ET and this
will form the basis of future studies.4.3. Individual specific rates of aneuploidy among donors
It was evident that there was a high degree of variability in the
incidence of chromosomal errors between individual donors. To the
Fig. 2. Incidence of aneuploidy did not differ between Day 8 blastocysts generated
from stimulated (n ¼ 82 blastocysts) vs non-stimulated (n ¼ 70 blastocysts) cycles of
OPU (A) but, in matched donors, did differ (P ¼ 0.004) in Day 8 blastocysts derived
from cycles of OPU-IVP compared to ovarian-stimulation, artificial insemination and
embryo recovery (in vivo) (B).
Fig. 3. Incidence of aneuploidy in Day 8 blastocysts from stimulated (n ¼ 82 blasto-
cysts) and non-stimulated (n ¼ 70 blastocysts) cycles of OPU. Data represent propor-
tion aneuploid Grade 1 hatched/hatching blastocysts, and Grade 1 and 2 expanded
blastocysts. The proportion aneuploid was less (P < 0.01) for Stage 8/9 (hatching/
hatched) blastocysts compared to Stage 7 (expanded) blastocysts. However, there was
an interaction (P < 0.05) between ovarian-stimulation treatment and blastocyst stage/
grade. Aneuploidy decreased as stage/grade improved for blastocysts from non-
stimulated cycles but was greatest for expanded Grade 1 blastocysts from stimulated
cycles.
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genetic associations of elevated aneuploidy. These may be resolved
by genome-wide association studies, should a sufficiently large
number of samples such as these become available.
A number of intriguing observations also arise in this context
when comparing stimulated vs non-stimulated cycles. For donors
859, 805 and 36, chromosomal errors were detected in blastocysts
derived almost exclusively from non-stimulated cycles. Likewise,
the incidence of chromosomal errors was less in stimulated than
non-stimulated cycles for 827 and 701. In contrast, it increased with
ovarian stimulation for donors 29, 835 and 840. Although variable
donor responses to ovarian stimulation, in terms of blastocyst
yields, are well documented in both cattle [57] and humans [58], to
the best of our knowledge, the relationship between ovarian115stimulation regimen and chromosomal error rate between indi-
vidual donors is not known. Furthermore, whilst early animal
[59e61] and subsequent human [62,63] studies reported delete-
rious effects of ovarian stimulation, more recent stimulation pro-
tocols do not appear to increase the incidence of chromosomal
errors [64e66]. Donor variation in the nature/incidence of aneu-
ploidy following ovarian stimulation clearly merits further
investigation.4.4. Nature and incidence of aneuploidy
The prevalence of any one given chromosomal error is a balance
between the competing factors of initial error rate in the gamete
and differential survival at any one given stage. For instance, an
extra chromosome 16 is the most common of all trisomies in
humans but is not seen at all in live births as it invariably leads to
spontaneous abortions. Despite obvious evidence of selection in
humans, the consensus is that smaller chromosomes such as 16, 21
and 22 at least are more prone to non-disjunction and that most
monosomies are lost before a pregnancy is clinically recognised
[67]. In contrast to humans, the larger of the cattle chromosomes in
the current study appeared to be more prone to nondisjunction
(Fig. 6). The number of monosomies and trisomies also appeared to
be particularly high for chromosomes 14 and 15. The reasons for
these apparent species differences are unclear and require confir-
mation by further studies. Nevertheless, the numerically greater
number of trisomies thanmonosomies (Fig. 5), and the fact that our
assay detects only meiotic trisomies but monosomies of both
meiotic and mitotic origin, suggest that the more lethal mono-
somies have been selected against by the blastocyst stage.
Fig. 4. Incidence of aneuploidy in Day 8 blastocysts (all IETS Stage 7e9 blastocysts;
n ¼ 152) per donor averaged across stimulated and non-stimulated cycles. The pro-
portion of aneuploid blastocysts differed (P ¼ 0.008) between donors.
Fig. 5. Nature of chromosomal errors expressed as a proportion of total errors in Day 8
blastocysts (n ¼ 40). These did not differ significantly between stimulated (-) and
non-stimulated (,) cycles of OPU. ‘(M)’ and ‘(P)’ refers to maternal and paternal origin
respectively. ‘Double aneuploidy’ refers to combinations of maternal trisomy and/or
maternal monosomy on two chromosomes.
Fig. 6. Chromosome-specific incidence of aneuploidy in blastocysts (n ¼ 152). (A)
Expressed by individual chromosome identifying incidences of monosomy and tri-
somy. (B) Combined aneuploidy categories grouped by ‘small (20e29), medium
(10e19) and large (1e9)’ chromosomes. Data are for blastocysts from stimulated and
non-stimulated cycles of OPU-IVP.
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The high degree of perfect concordance in the incidence (pro-
portionately 0.94) of chromosomal errors between the TE and ICM
(Fig. 8) is punctuated by nine non-concordant cases. Of these, two
demonstrated that there was clearly an error in both lineages
Fig. 7. Incidence of aneuploidy for the inner-cell mass (ICM) and trophectoderm (TE)
cell lineages for blastocysts derived from stimulated (n ¼ 82 blastocysts) and non-
stimulated (n ¼ 70 blastocysts) cycles of OPU-IVP.
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only maternal chromosomes in the otherwise diploid ICM, a pre-
sumed mechanism of complete loss of the paternal genome,
confined to the ICM and therefore occurring in the very early
cleavage divisions. The second had only paternal chromosomes
(less chromosomes 19 and 29 which were lost in the TE) but with
traces of the maternal genome in the ICM. This suggests loss of the
maternal genome in most of both lineages, again relatively early in
cleavage and perhaps independent post-zygotic loss of chromo-
somes 19 and 29.
Of the false positive results, all had a triploid or hypotriploid TE
that would suggest that, although the ICM was chromosomally
normal, the chances of a normal ongoing pregnancy and live birth
would be minimal because of insufficiency of the chromosomally
abnormal placenta. Again, a mechanism of loss of the extra genomeFig. 8. Depiction of the 152 OPU-IVP blastocysts analysed for chromosome abnor-
malities in both ICM and TE lineages. The perfect concordance of 112 euploid and 31
abnormal embryos indicates an incidence proportionately of 0.94. This increases to 145
(proportionately 0.95) for perfect and imperfect concordance combined. The 4 so
called “false positives” should, most likely, not be transferred as they may lead to
placental insufficiency, leaving only 3 (proportionately 0.02) in which a genuine
misdiagnosis (false negative) was made.
117is presumed. If we accept that the broader purpose of PGT-A is
primarily to spot an abnormality (and hence informwhether or not
to proceed with embryo transfer) we can be confident that PGT-A
was informative for these cases also. Two of the remaining false
negatives failed to identify an otherwise triploid embryo that
would fail to develop; the final false negative was a UPD; an
effective “misdiagnosis rate” of only 2%.
The presence of an abnormality in either the ICM or the TE is an
example of confined mosaicism and has been extensively reported
for human embryos [25,68]. Moreover, the high degree of concor-
dance we observed is near identical to that observed in human
studies [25,26]. This might be expected for chromosomal errors of
meiotic origin that are clonally propagated [53]. Destouni et al. [69]
reported that paternal chromosomal errors observed in bovine
cleavage stage embryos occur as mosaics and are the result of
dispermic fertilization, which can also lead to triploid and complex
aneuploid mosaics in human embryos [70]. Our results indicate
that (hypo)triploid embryos can have an extra maternal (diploid
egg) or paternal (dispermy or, less likely, diploid sperm) origin in
roughly equal numbers. The fact that we observed triploid/diploid
mosaics and, when chromosomes were lost in the hypotriploid
embryos, they were exclusively from the parent that donated the
extra genome, suggests active mechanisms to evict the offending
chromosomes very early in development (e.g. around fertilization
or first cleavage). Alternative animal models (non-human primates
and mice) have demonstrated that cells from one lineage with
chromosomal errors can be preferentially removed by fragmenta-
tion [71] or by apoptosis which leads to disproportionate presence
in the other [72].
It is noteworthy that we did not detect any blastocysts that we
might describe as “chaotic” (i.e. multiple errors, different in each
lineage of both number and structure). These are well described in
human embryos but, had we seen them, we would have expected
extensive loss of chromosomes from both parents together (not just
one or the other), a higher degree of structural abnormality and a
greater level of mosaicism. Our combined SNP-array analyses
(based on Karyomapping, G-G and BAF/LRR plots) of ICM and TE
cells was able to detect aneuploidies of both meiotic and mitotic
origin, albeit not at cell-to-cell level [15]. Errors of mitotic origin
constitute the predominant source of chromosomal mosaicism in
the human preimplantation embryo [73]. Using a SNP-array based
procedure not dissimilar to that employed in the current study, but
on single blastomeres from cleavage-stage (Day 2e3) bovine em-
bryos, Tsuiko et al. [74] observed a higher incidence of chromo-
somal abnormalities following stimulated cycles of oocyte recovery
and in vitro culture (OPU-IVP) compared to stimulated cycles with
in vivo embryo recovery. This is in keeping with observations from
the current study indicating that IVP, rather than ovarian stimula-
tion, is the major cause of chromosomal errors in ART. Embryos in
the study of Tsuiko et al. [74], however, displayed a broad range of
whole chromosome, segmental and ploidy aberrations which is
consistent with the high incidence (15e90%) of mosaicism
observed in cleavage stage human embryos [73]. Mosaicism
generally decreases by the blastocyst stage in humans, leading
Fragouli et al. [53] to conclude that TE biopsy for PGT-A is likely to
provide a more reliable indication of cytogenetic status. Overall,
therefore, our observations support the use of PGT-A in TE biopsies
from embryos undergoing genomic evaluation in commercial cattle
breeding.
4.6. Concluding remarks
The current study demonstrates that stimulated ovarian cycles
(with ‘coasting’) prior to oocyte collection (OPU) leads to greater
yields of blastocysts without compromising chromosome integrity.
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particularly as we have established that trophectoderm biopsies
represent the ploidy status of the overall embryo. This is significant
as it means that our contemporary SNP-array based platform can be
used to undertake genomic evaluations (gEBVs) and PGT-A as-
sessments (for future pregnancy outcome evaluations) in bovine
blastocysts simultaneously. One of the criticisms of human PGT-A is
that the embryo biopsy procedure may compromise the develop-
mental potential of the embryo thereby negating any positive effect
gained from aneuploidy screening. In cattle embryos, given that the
primary purpose of biopsy is to assess gEBV by SNP array, PGT-A can
only confer an advantage. Consistent with the results of Tsuiko et al.
[74], our finding that in vitromaturation/culture rather than ovarian
stimulation per se is the primary cause of chromosomal abnor-
malities in pre-implantation embryos offers hope for future
improvement. In theory, improvement in culture conditions to
mimic more closely the in vivo environment could help reduce
chromosome abnormalities further, particularly if donors that are
prone to higher levels of error (as revealed in this study) are
eliminated from the breeding programme. Finally, our data provide
fundamental insight into the mechanisms of the origin of chro-
mosome error in early development.
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